RA Capital's massive block sale signals a sharp reduction in conviction and likely an exit strategy. Monitor for further sales by the remaining funds (Nexus Fund III holds 4.9%) and any potential change in activist demands or board representation. The stock may face continued selling pressure.
Price Chart
Executive Summary
RA Capital Management has filed Amendment No. 2 to its Schedule 13D, reporting a massive reduction in its stake in Sionna Therapeutics. On September 17, 2026, RA Capital Healthcare Fund, L.P. sold 3,415,011 shares in a block trade and 33,800 shares in open market sales, reducing the group's aggregate beneficial ownership from a prior level to 6,476,193 shares (14.3% of shares outstanding as of July 31, 2026). This represents a significant de-escalation and partial exit by the activist investor.
Key Financial Metrics
Key Facts
- RA Capital Management group filed Amendment No. 2 to Schedule 13D on September 21, 2026.
- On September 17, 2026, RA Capital Healthcare Fund, L.P. sold 3,415,011 shares in a block sale and 33,800 shares in open market sales.
- The group's aggregate beneficial ownership is now 6,476,193 shares, representing 14.3% of outstanding common stock (based on 45,212,399 shares outstanding as of July 31, 2026).
- The filing does not disclose the prior stake percentage, but the sale of over 3.4 million shares in a single day signals a major reduction.
- RA Capital Nexus Fund III ceased to be a >5% beneficial owner on November 17, 2025, per the filing.
Financial Impact
RA Capital sold approximately 3,448,811 shares on September 17, 2026, at a weighted average price of $6.32 for the block sale and $7.46 for the open market sale, representing a total transaction value of approximately $21.8 million.
Risk Factors
- Continued dilution from further RA Capital sales.
- Loss of activist catalyst and potential strategic alternatives.
- Negative market perception from a large insider/activist exit.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001346824-26-000239 |
| Document: 0001346824-26-000239-index.html | 0001346824-26-000239 |
| Document: 0001346824-26-000239.txt | 0001346824-26-000239 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 4w ago | Institutional Cluster | $6.02 $5.15 | ▼ −14.45% | ▼ −13.26% | $3.60 (−40.20%) |
Sep 21, 2026 4w ago | SC 13D/A | $6.02 $5.15 | ▲ +14.45% | ▲ +13.26% | $3.60 (+40.20%) |
Sep 17, 2026 5w ago | 144 | $5.96 $5.23 | ▲ +12.25% | ▲ +13.52% | $3.60 (+39.60%) |
Aug 10, 2026 11w ago | 8-K | $4.50 $5.91 | ▼ −31.33% | ▼ −31.38% | $3.60 (+20.00%) |
Aug 6, 2026 11w ago | 8-K | $49.61 $6.54 | ▼ −86.82% | ▼ −88.03% | $3.60 (−92.74%) |
Jul 9, 2026 15w ago | Insider Cluster | $45.29 $45.29 | · 0.00% | ▲ +0.56% | $3.60 (−92.05%) |
Jul 9, 2026 15w ago | Insider Cluster | $45.29 $45.29 | · 0.00% | ▼ −0.56% | $3.60 (+92.05%) |
Jul 7, 2026 15w ago | Insider Cluster | $44.00 $42.59 | ▲ +3.20% | ▲ +4.07% | $3.60 (+91.82%) |
Jul 2, 2026 16w ago | Insider Cluster | $43.12 $43.95 | ▲ +1.92% | ▲ +2.21% | $3.60 (−91.65%) |
Jun 11, 2026 19w ago | Institutional Cluster | $36.05 $36.73 | ▲ +1.89% | ▲ +1.45% | $3.60 (−90.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers